Spot Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Spot Trading’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,650	Closed	-$2K	–	3522
2016 Q3	$2K	Hold	5,650	–	–	﹤0.01%	2990
2016 Q2	$3K	Buy	+5,650	New	+$3K	﹤0.01%	3196
2014 Q3	–	Sell	-10,825	Closed	-$33K	–	5164
2014 Q2	$33K	Buy	+10,825	New	+$33K	﹤0.01%	4045

Spot Trading's RXII Position: Q4 2016 in Review

Spot Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 5,650 shares — an estimated $2K sold.

Spot Trading first reported a position in RXII in Q2 2014 and held it in 3 quarters. The position peaked at $33K in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Spot Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Spot Trading sold 5,650 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $2K.
Spot Trading first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 3 quarters.
Spot Trading's GALENA BIOPHARMA INC COM position peaked at $33K in Q2 2014.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.